EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension

O. Sitbon, M. Delcroix, E. Bergot, A. Boonstra, J. Granton, D. Langleben, P.E. Subias, N. Galie, T. Pfister, J.C. Lemarie, G. Simonneau

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)210-217
JournalThe American Heart Journal
Volume167
Issue number2
DOIs
Publication statusPublished - 2014

Cite this

Sitbon, O., Delcroix, M., Bergot, E., Boonstra, A., Granton, J., Langleben, D., Subias, P. E., Galie, N., Pfister, T., Lemarie, J. C., & Simonneau, G. (2014). EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension. The American Heart Journal, 167(2), 210-217. https://doi.org/10.1016/j.ahj.2013.08.007